Dybbs Michael
Insider CIK 1601264 · STRO Director · VSAR Director · DMTX Director · KLRS Director · SGP Director · NKTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NKTX Nkarta, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 37,000 | — | $0 | 37,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2026-06-05 | 2026-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | A Award deriv | 2026-02-05 | 2026-02-09 | 27,400 | — | $0 | 27,400 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-12-23 | 2025-12-29 | 1,500 | — | $0 | 1,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-06-06 | 2025-06-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 46,000 | — | $0 | 46,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2025-04-10 | 2025-04-11 | 18,000 | — | $0 | 18,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 22,500 | — | $0 | 22,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-06-06 | 2024-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2022-06-06 | 2022-06-08 | 18,500 | — | $0 | 18,500 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2021-06-13 | 2021-06-15 | 16,511 | — | $0 | 16,511 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2021-06-03 | 2021-06-07 | 18,500 | — | $0 | 18,500 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 10,700 | — | $0 | 10,700 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2020-06-05 | 2020-06-08 | 12,000 | — | $0 | 12,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2019-06-17 | 2019-06-19 | 11,610 | — | $0 | 11,610 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | A Award deriv | 2018-09-26 | 2018-09-27 | 26,033 | — | $0 | 26,033 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 32,069 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2017-05-25 | 2017-05-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2016-05-19 | 2016-05-23 | 32,069 | — | $0 | 32,069 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion deriv | 2015-10-27 | 2015-10-29 | 3,208,711 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion | 2015-10-27 | 2015-10-29 | 1,097,745 | — | $0 | 1,097,745 | SEC↗ |
| DMTX Dimension Therapeutics, In | P Buy | 2015-10-27 | 2015-10-29 | 961,538 | $13.00 | $12.50M | 2,059,283 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2014-03-20 | 2014-03-24 | 35,000 | — | $0 | 35,000 | SEC↗ |